Jyong Biotech Ltd (MENS)

Apr 30, 2026

Jyong Biotech Delays Annual 20-F (Yearly Report) - The Globe and Mail

Apr 30, 2026

Apr 28, 2026

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio - Yahoo Finance

Apr 28, 2026

Apr 28, 2026

Two plant-based prostate drug candidates move toward broader markets - Stock Titan

Apr 28, 2026

Apr 27, 2026

Short Interest in Jyong Biotech Ltd. (NASDAQ:MENS) Decreases By 43.2% - MarketBeat

Apr 27, 2026

Apr 24, 2026

CEO-linked entities report 33.34% Jyong Biotech (MENS) stake via trust - Stock Titan

Apr 24, 2026

Apr 22, 2026

Jyong Biotech (MENS) Management Strategy | Q1 2025: Earnings ReportPre Earnings - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 21, 2026

MENS Stock Price, Quote & Chart | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

Apr 21, 2026

Apr 20, 2026

Who Backs Jyong Biotech (MENS) Stock (Risk Aversion) 2026-04-20Investment Picks - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 20, 2026

Apr 18, 2026

Ming Tsan Hsu Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Pang Chieh Chi Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Feng Lin Hsu Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Fu Feng Kuo Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 17, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Significant Decrease in Short Interest - MarketBeat

Apr 17, 2026

Apr 14, 2026

Jyong Biotech Ltd. Live Share Prices and Trades. MENS.US Live Streaming Share Prices. - London South East

Apr 14, 2026

Apr 14, 2026

Jyong Biotech (NASDAQ: MENS) CFO ZHANG WEI files initial Form 3 - Stock Titan

Apr 14, 2026

Apr 13, 2026

Wei (vivi) Zhang Net Worth (2026) - GuruFocus

Apr 13, 2026

Apr 11, 2026

MENS Options Volatility — NASDAQ:MENS - TradingView

Apr 11, 2026

Apr 11, 2026

MENS Options Chain — NASDAQ:MENS - TradingView

Apr 11, 2026

Apr 10, 2026

MENS News | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

Apr 10, 2026

Apr 08, 2026

Jyong Biotech (MENS) CEO Kuo reports 25,349,500-share indirect stake on Form 3 - Stock Titan

Apr 08, 2026

Apr 06, 2026

Is Jyong Biotech (MENS) Stock Rebounding | Price at $2.47, Up 0.82%Real Trader Network - Newser

Apr 06, 2026

Apr 04, 2026

MENS PE Ratio & Valuation, Is MENS Overvalued - Intellectia AI

Apr 04, 2026

Apr 01, 2026

Director of Jyong Biotech (MENS) files Form 3 showing 3,000 common shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director Hsu Feng-Lin reports 3,000 Jyong Biotech (MENS) shares on Form 3 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Jyong Biotech (MENS) discloses holding 3,000 shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Jyong Biotech (MENS) director Fan Hung-Shu files initial Form 3 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Jyong Biotech (MENS) director files Form 3 with no insider trades - Stock Titan

Apr 01, 2026

Mar 29, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March - Defense World

Mar 29, 2026

Mar 28, 2026

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2 - The Manila Times

Mar 28, 2026

Mar 27, 2026

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS-2 - Bitget

Mar 27, 2026

Mar 16, 2026

Jyong Biotech Ltd PE Ratio (TTM) & PE Ratio (TTM) ChartsMENS - GuruFocus

Mar 16, 2026

Mar 15, 2026

Chinese firm sues Taiwan’s Jyong Biotech Ltd. in Cayman to enforce ¥152M China judgment - OffshoreAlert

Mar 15, 2026

Mar 15, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Large Decrease in Short Interest - MarketBeat

Mar 15, 2026

Mar 12, 2026

Jyong Biotech 'not aware' of any material information amid share price movement - MSN

Mar 12, 2026

Mar 11, 2026

MENS Earnings History & Surprises | EPS & Revenue Results | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

Mar 11, 2026

Feb 28, 2026

MENS Should I Buy - Intellectia AI

Feb 28, 2026

Feb 26, 2026

Jyong Biotech (NASDAQ:MENS) Stock Price Down 12.3%Time to Sell? - MarketBeat

Feb 26, 2026

Feb 23, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Feb 23, 2026

Feb 15, 2026

Jyong Biotech Strengthens Preventive Medicine Position With Positive Phase II Data And Asian Expansion - BioPharma APAC

Feb 15, 2026

Feb 13, 2026

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia - The Manila Times

Feb 13, 2026

Feb 12, 2026

MENS Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 12, 2026

Feb 12, 2026

Prostate cancer therapy also lowers cholesterol in 2-year trial - Stock Titan

Feb 12, 2026

Feb 10, 2026

CEO Fu-Feng Kuo, Jyong Biotech Ltd.'s (NASDAQ:MENS) largest shareholder sees value of holdings go down 23% after recent drop - Yahoo Finance

Feb 10, 2026

Feb 07, 2026

Jyong Biotech appoints Wei (Vivi) Zhang as chief financial officer By Investing.com - Investing.com India

Feb 07, 2026

Feb 06, 2026

Jyong Biotech appoints Wei (Vivi) Zhang as chief financial officer - Investing.com Nigeria

Feb 06, 2026

Feb 06, 2026

Jyong Biotech Appoints Veteran Capital Markets Executive Wei Zhang as Chief Financial Officer - TipRanks

Feb 06, 2026

Feb 02, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Update - MarketBeat

Feb 02, 2026

Jan 30, 2026

Jyong Biotech subsidiary announces phase II data for MCS-8 - TipRanks

Jan 30, 2026